On Apr. 29, 2022, Moderna announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec that will support a long-term strategic partnership with the Government of Canada to enhance pandemic preparedness.

This milestone followed the signing of a Memorandum of Understanding between Moderna and the Government of Canada in August 2021. Once the facility was certified by Health Canada, it was expected to provide onshore respiratory vaccine manufacturing capabilities and support future pandemic readiness.